350
Participants
Start Date
May 31, 1999
Primary Completion Date
February 28, 2006
Study Completion Date
December 31, 2009
asparaginase
cytarabine
mercaptopurine
methotrexate
prednisolone
vincristine sulfate
Our Lady's Hospital for Sick Children Crumlin, Dublin
Hopital Universitaire Des Enfants Reine Fabiola, Brussels
Nuovo Ospedale San Gerardo at University of Milano-Bicocca, Monza
Ospedale San Gerardo, Monza
St. Jude Children's Research Hospital, Memphis
Ostra Sjukhuset, Gothenburg
Hopital Saint-Louis, Paris
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston
St. Anna Children's Hospital, Vienna
University Hospital Motol, Prague
University Medical Center Hamburg - Eppendorf, Hamburg
Medizinische Hochschule Hannover, Hanover
Erasmus MC - Sophia Children's Hospital, Rotterdam
Birmingham Children's Hospital, Birmingham
Institute of Child Health at University of Bristol, Bristol
Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust, Cambridge
Leeds Cancer Centre at St. James's University Hospital, Leeds
Leicester Royal Infirmary, Leicester
Royal Liverpool Children's Hospital, Alder Hey, Liverpool
Royal London Hospital, London
Great Ormond Street Hospital for Children NHS Trust, London
Central Manchester and Manchester Children's University Hospitals NHS Trust, Manchester
Sir James Spence Institute of Child Health, Newcastle upon Tyne
Queen's Medical Centre, Nottingham
Oxford Radcliffe Hospital, Oxford
Children's Hospital - Sheffield, Sheffield
Southampton University Hospital NHS Trust, Southampton
Royal Marsden NHS Foundation Trust - Surrey, Sutton
Royal Belfast Hospital for Sick Children, Belfast
Royal Aberdeen Children's Hospital, Aberdeen
Royal Hospital for Sick Children, Edinburgh
Royal Hospital for Sick Children, Glasgow
Childrens Hospital for Wales, Cardiff
Dutch Childhood Oncology Group
OTHER